LLY
776.45
-2.39%↓
JNJ
152.33
+0.12%↑
ABBV
182.26
-2.5%↓
NVO
68.53
+1.17%↑
UNH
308.74
+2.11%↑
LLY
776.45
-2.39%↓
JNJ
152.33
+0.12%↑
ABBV
182.26
-2.5%↓
NVO
68.53
+1.17%↑
UNH
308.74
+2.11%↑
LLY
776.45
-2.39%↓
JNJ
152.33
+0.12%↑
ABBV
182.26
-2.5%↓
NVO
68.53
+1.17%↑
UNH
308.74
+2.11%↑
LLY
776.45
-2.39%↓
JNJ
152.33
+0.12%↑
ABBV
182.26
-2.5%↓
NVO
68.53
+1.17%↑
UNH
308.74
+2.11%↑
LLY
776.45
-2.39%↓
JNJ
152.33
+0.12%↑
ABBV
182.26
-2.5%↓
NVO
68.53
+1.17%↑
UNH
308.74
+2.11%↑
24h
Corrente
Minimo
1.76
Massimo
1.87
Raccomandazioni | Acquista |
---|---|
Previsioni per 12 mesi | +440.54% upside |
Utili prossimi | 11 ago 2025 |
---|
Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.
10 mar 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
LeggI
10 mar 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
LeggI
10 mar 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
LeggI
10 mar 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
LeggI
10 mar 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
LeggI
10 mar 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
LeggI
10 mar 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
LeggI
Modifica del prezzo
By TipRanks
Previsioni per 12 mesi
Media 10 USD 440.54%
Alto 16 USD
Basso 4 USD
Basato su 2 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Fortress Biotech Inc - Dist negli ultimi 3 mesi.
By TipRanks
Acquista
2 ratings
2
Acquista
0
Mantieni
0
Vendi
Basato sugli analisti di 2 che hanno fornito valutazioni azionarie a Fortress Biotech Inc - Dist negli ultimi 3 mesi.
$